Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

Similar articles for PubMed (Select 9884387)

1.

Age-dependent impairment of angiogenesis.

Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM.

Circulation. 1999 Jan 5-12;99(1):111-20.

2.

Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia.

Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM, Symes JF.

Circulation. 1994 Nov;90(5 Pt 2):II228-34.

PMID:
7525111
3.

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice.

Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M, Annex B, Peters K, Isner JM.

Circulation. 1999 Jun 22;99(24):3188-98.

5.

Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.

Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM.

Circulation. 1995 Nov 1;92(9 Suppl):II365-71.

PMID:
7586439
6.

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, Symes JF, Bauters C, Isner JM.

Circulation. 1997 Oct 21;96(8):2667-74.

7.

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.

Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM.

J Clin Invest. 1998 Jun 1;101(11):2567-78.

8.

Mouse model of angiogenesis.

Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM.

Am J Pathol. 1998 Jun;152(6):1667-79.

9.

Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor.

Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM.

Circulation. 1995 Jun 1;91(11):2802-9.

10.

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion.

Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM.

Circulation. 1996 Dec 15;94(12):3281-90.

11.

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM.

Am J Pathol. 1999 Feb;154(2):355-63.

12.

Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene.

Tsurumi Y, Kearney M, Chen D, Silver M, Takeshita S, Yang J, Symes JF, Isner JM.

Circulation. 1997 Nov 4;96(9 Suppl):II-382-8.

PMID:
9386128
13.

Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.

Dai Q, Huang J, Klitzman B, Dong C, Goldschmidt-Clermont PJ, March KL, Rokovich J, Johnstone B, Rebar EJ, Spratt SK, Case CC, Kontos CD, Annex BH.

Circulation. 2004 Oct 19;110(16):2467-75. Epub 2004 Oct 11.

14.

Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis.

Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, Cook JJ.

Cardiovasc Res. 2001 Feb 16;49(3):618-25.

15.

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM.

Am J Pathol. 1998 Aug;153(2):381-94.

16.

Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia.

Hopkins SP, Bulgrin JP, Sims RL, Bowman B, Donovan DL, Schmidt SP.

J Vasc Surg. 1998 May;27(5):886-94; discussion 895.

PMID:
9620141
17.

Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.

Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Lévy BI.

Circ Res. 2002 May 31;90(10):1072-9.

18.

Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.

Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI.

Circ Res. 2001 Oct 12;89(8):678-83.

19.

Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.

Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, deGasparo M, Henrion D, Levy BI.

Hypertension. 2002 Mar 1;39(3):830-5.

20.

Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb.

Silvestre JS, Mallat Z, Duriez M, Tamarat R, Bureau MF, Scherman D, Duverger N, Branellec D, Tedgui A, Levy BI.

Circ Res. 2000 Sep 15;87(6):448-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk